Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 22.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 20.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Company is filing this Amendment only to include Item 5.02 to provide information about the NeuroOne Medical Technologie |
| 13.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 14.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
Unternehmen & Branche
| Name | NEUROONE MEDICAL TECHNOLOGIES Corp |
|---|---|
| Ticker | NMTC |
| CIK | 0001500198 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 40,2 Mio. USD |
| Beta | 0,58 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 2,892,635 | -1,437,890 | -0.03 | 8,577,602 | 6,401,925 |
| 2025-09-30 | 10-K | 9,097,692 | -3,605,374 | -0.09 | 10,785,647 | 7,072,522 |
| 2025-06-30 | 10-Q | 1,696,050 | -1,500,868 | -0.03 | 10,819,481 | 8,177,453 |
| 2025-03-31 | 10-Q | 1,386,550 | -2,270,607 | -0.07 | 4,456,691 | 1,125,858 |
| 2024-12-31 | 10-Q | 3,274,167 | 1,785,322 | 0.06 | 6,494,450 | 2,935,292 |
| 2024-09-30 | 10-K | 3,453,003 | -12,318,110 | -0.46 | 5,369,940 | 822,013 |
| 2024-06-30 | 10-Q | 825,776 | -2,767,525 | -0.10 | 4,912,597 | 3,011,727 |
| 2024-03-31 | 10-Q | 1,377,294 | -2,855,090 | -0.11 | 5,394,902 | 3,854,443 |
| 2023-12-31 | 10-Q | 977,649 | -3,344,900 | -0.14 | 5,822,378 | 4,418,156 |
| 2023-09-30 | 10-K | 1,952,441 | -11,859,491 | -0.65 | 8,097,314 | 6,249,404 |
| 2023-06-30 | 10-Q | 629,906 | -3,468,773 | -0.20 | 5,758,124 | 3,921,298 |
| 2023-03-31 | 10-Q | 466,176 | -3,522,828 | -0.21 | 7,205,106 | 5,532,824 |
| 2022-12-31 | 10-Q | 114,579 | -1,732,769 | -0.11 | 9,660,220 | 8,171,776 |
| 2022-09-30 | 10-K | 171,169 | -9,999,613 | -0.63 | 12,822,609 | 9,604,364 |
| 2022-06-30 | 10-Q | 32,049 | -2,759,727 | -0.17 | 11,570,748 | 10,618,270 |
| 2022-03-31 | 10-Q | 36,584 | -3,058,067 | -0.19 | 14,088,723 | 13,122,449 |
| 2021-12-31 | 10-Q | 33,748 | -2,807,475 | -0.18 | 17,183,454 | 15,947,800 |
| 2021-09-30 | 10-K | 178,146 | -9,948,168 | -0.93 | 7,938,496 | 6,553,901 |
| 2021-06-30 | 10-Q | 40,096 | -2,951,609 | -0.25 | 9,808,723 | 8,854,905 |
| 2021-03-31 | 10-Q | 18,240 | -2,393,916 | 11,917,071 | 10,860,013 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -15,363 | 0.74 | -11,368.62 | -18,6% | |
| 2026-03-13 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -100 | 0.80 | -80.00 | -0,1% | |
| 2026-03-12 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -817 | 0.80 | -653.60 | -1,1% | |
| 2026-03-11 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -2,109 | 0.80 | -1,687.20 | -2,8% | |
| 2026-03-10 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -11,611 | 0.80 | -9,288.80 | -15,2% | |
| 2026-03-01 | Wambeke David J. | Officer, Chief Business Officer | Open Market Purchase | 1,000,000 | 0.67 | 670,400.00 | +1095,4% | |
| 2025-09-05 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -30,000 | 0.74 | -22,203.00 | -36,3% | |
| 2025-06-04 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -10,000 | 0.58 | -5,804.00 | -9,5% | |
| 2025-05-22 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -8,967 | 0.62 | -5,586.44 | -9,1% | |
| 2025-05-21 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -14 | 0.65 | -9.10 | 0,0% | |
| 2025-05-20 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -3,013 | 0.66 | -1,975.93 | -3,2% | |
| 2025-05-19 | Christianson Mark | Officer, Business Development Director | Open Market Sale | -8,006 | 0.67 | -5,329.59 | -8,7% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.